Cyclooxygenase-2 expression in primary human colorectal cancers and bone marrow micrometastases

Digestive and Liver Disease

Volumn 36, Issue 6, 2004, Pages 392-397

  Sheehan, Katherine M ^a   Cahill, R A ^b   McGeal, G ^b   Steele, C ^a   Byrne, M F ^a   Kirwan, W O ^b   Kay, E W ^a   Fitzgerald, D J ^a   Redmond, H P ^b   Murray, F E ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b University College Cork and INFANT Centre   (Ireland)

Author keywords

Colorectal cancer; Cyclooxygenase 2; Metastasis

Indexed keywords

AVIDIN; BIOTIN; CYCLOOXYGENASE 2; CYTOKERATIN 18; ISOENZYME; MEMBRANE PROTEIN; PEROXIDASE; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CANCER STAGING; CLINICAL ARTICLE; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM CELL; FEMALE; FISHER EXACT TEST; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; ILIAC CREST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; METASTASIS POTENTIAL; PILOT STUDY; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TISSUE SECTION; BIOSYNTHESIS; BONE MARROW CANCER; COLORECTAL TUMOR; ENZYME IMMUNOASSAY; ENZYMOLOGY; METASTASIS; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; BONE MARROW NEOPLASMS; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PEROXIDASES; PILOT PROJECTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 85047694342     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(04)00093-3     Document Type: Article

References (27)

1. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmuller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992;340:685-9.
2. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-2 protein in human colon cancer. Cancer Res 1995;55:2556-9.
3. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Upregulation of cyclooxygenase-2 gene expression in human colorectal adenomas and carcinomas. Gastroenterology 1994;107:1183-8.
4. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, et al. Expression of cyclooxygenase-1 and 2 in human colon cancer. Cancer Res 1995;55:3785-9.
5. Williams CS, Smalley W, DuBois RN. Aspirin use and the potential mechanisms for colorectal cancer prevention. J Clin Invest 1997;100:1325-9.
6. Giardiello FM, Hamilton SR, Krush AJ, Tersmette AC, Booker SV, Kelley NC, et al. Treatment of colonic and rectal adenoma with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-6.
7. Moorghen M, Ince P, Finney KJ, Sunter JP, Appleton DR, Watson JR. A protective effect of sulindac against chemically induced primary colonic tumours in mice. J Pathol 1988;156:341-7.
8. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, et al. The effect of Celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52.
9. Buecher B, Broquet A, Bouancheau D, Heymann MF, Jany A, Denis MG, et al. Molecular mechanisms involved in the antiproliferative effect of two COX-2 inhibitors, nimesulide and NS-398, on colorectal cancer cell lines. Dig Liver Dis 2003;35:557-65.
10. Δ716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 1996;87:803-9.
11. Trifan OC, Smith RM, Thompson BD, Hla T. Overexpression of cyclooxygenase-2 induces cell cycle arrest. J Biol Chem 1999;274:34141-7.
12. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
13. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, et al. Inhibition of angiogenesis by NSAIDs: Insight into the mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999;5:1418-23.
14. Coffey RJ, Hawkey CJ, Damstrup L, Graves-Deal R, Daniel VC, Dempsey PJ, et al. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci USA 1997;94:657-62.
15. Sheehan KM, Sheahan K, O'Donoghue DP, MacSweeney F, Conroy RM, Fitzgerald DJ, et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. J Am Med Assoc 1999;282:1254-7.
16. Tomozawa S, Tsuno NH, Sunami E, Hatano K, Kitayama J, Osada T, et al. Cyclooxygenase-2 over-expression correlates with tumour recurrence, especially haematogenous metastasis of colorectal cancer. Br J Cancer 2000;83:324-6.
17. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94:3336-40.
18. Tomozawa S, Nagawa H, Tzuno N, Hatano K, Osada T, Kitayama J, et al. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer 1999;81: 1274-9.
19. Chen WS, Wei SJ, Lim JM, Hsiao M, Lou-liu J, Yang WK. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. Int J Cancer 2001;91:894-9.
20. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000;89:2637-45.
21. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase upregulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-16.
22. Jauch KW, Heiss MM, Gruetzner U, Funke I, Pantel K, Babic R, et al. Prognostic significance of bone marrow micrometastasis in patients with gastric cancer. J Clin Oncol 1996;14:1810-7.
23. Braun S, Pantel K, Muller P, Janni W, Hepp F, Kentenech CR, et al. Cytokeratin positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer. N Engl J Med 2000;342:525-33.
24. Pantel K, Izbicki JR, Passlick B, Anstwurm M, Haussinger K, Thetter O, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastasis. Lancet 1996;347:649-53.
25. Fiorucci S, Antonelli E. Cyclooxygenase isoenzymes. Structural basis for selective inhibition of cyclooxygenases by anti-inflammatory agents. Dig Liver Dis 2001;33:S2-7.
26. Hoff T, DeWitt D, Kaever V, Resch K, Goppelt-Struebe M. Differentiation-associated expression of prostaglandin G/H synthase in monocytic cells. FEBS Lett 1993;320:38-42.
27. Honn KV, Meyer J. Thromboxanes and prostacyclin: positive-negative modulators of tumour growth. Biochem Biophys Res Commun 1991;102:1122-9.